Organogenesis  Inc. logo

Organogenesis Inc.

ORGO | NASDAQ
Chart Builder DCF Calculator
$1.40
-$0.02 (-1.41%)
At close: Sep 21, 2026, 4:00 PM ET
$1.41
+$0.01 (+0.71%)
Pre-market: Sep 22, 2026, 5:43 AM ET

Market Data

Market Cap
$182.72M
Enterprise Value
$201M
Beta
1.29
Average Volume
984.9K
Shares Outstanding (Diluted)
128.67M
Shares Change YoY
1.44%
Institutional Ownership
48.58%
Exchange
NASDAQ
ISIN
US68621F1021

Price Performance

Price Change 1M
-23.5%
Price Change 3M
-42.4%
Price Change 6M
-42.9%
Price Change YTD
-70.0%
Price Change 1Y
-70.3%
Price Change 3Y
-64.7%
Price Change 5Y
-64.7%
1M CAGR (ann.)
-41.1%
1Y CAGR (ann.)
-69.3%
5Y CAGR (ann.)
-38.9%
All-Time CAGR
-18.0%

Valuation

PE Ratio
-1.69
Forward PE
8.55
PEG Ratio
-0.00
Forward PEG
0.02
PS Ratio
0.39
Forward PS
0.70
PB Ratio
0.63
P/FCF Ratio
8.64
P/Adj. FCF Ratio
26.64
P/OCF Ratio
5.60
EV/Sales
0.44
EV/EBIT
-5.78
EV/EBITDA
-42.51
EV/FCF
9.64
Earnings Yield
-59.3%
FCF Yield
11.6%
Adj. FCF Yield
3.8%

Financial Health

Net Cash
$46.1M
Total Debt
$66.95M
Cash & Short-Term Investments
$46.1M
Total Assets
$406.45M
Current Ratio
3.52
Quick Ratio
3.00
Debt / Equity Ratio
0.23
Debt / EBITDA
-14.16
Debt / FCF
3.21
OCF / Debt
0.48
Interest Coverage
0.00
Altman Z-Score
1.67
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
67.6%
Operating Profit Margin
-6.4%
EBITDA Margin
-1.0%
Net Profit Margin
-19.8%
FCF Margin
4.6%
Adj. FCF Margin
1.5%
SBC / Revenue
3.1%
SBC Impact (per share)
-67.5%

Returns

Return on Assets
-22.2%
Return on Equity
-24.2%
Return on Invested Capital
-8.1%
Return on Capital Employed
-8.3%
Return on Tangible Assets
-24.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-0.1%
Revenue CAGR 5Y
1.1%
Revenue CAGR 10Y
17.3%
EPS CAGR 3Y
-96.3%
EPS CAGR 5Y
-310.6%
EPS CAGR 10Y
-5.9%
FCF CAGR 3Y
108.6%
FCF CAGR 5Y
-5.5%
FCF CAGR 10Y
21.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.18
EPS Growth Est (next Q)
-198.6%
Revenue Est (next Q)
$52.09M
Revenue Growth Est (next Q)
-65.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2.50
Price Target Upside
78.6%

Cash Flow

Operating Cash Flow
$31.97M
Free Cash Flow
$20.84M
Adj. Free Cash Flow
$6.76M
FCF Per Share
$0.16
OCF Per Share
$0.25
OCF/S Ratio
7.0%

Income Statement

Revenue
$456.54M
Gross Profit
$308.56M
Operating Income
$-29.15M
EBITDA
$-4.73M
Net Income
$-90.23M
EPS (Diluted)
-$0.83
Revenue / Employee
$534.59K
Profit / Employee
$-105.66K
Employees
854

© 2026 bestshares.com. All rights reserved.